HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis.

AbstractBACKGROUND:
Paraquat is an effective and widely used herbicide but is also a lethal poison. In many developing countries paraquat is widely available and inexpensive, making poisoning prevention difficult. However most of the people who become poisoned from paraquat have taken it as a means of suicide.Standard treatment for paraquat poisoning both prevents further absorption and reduces the load of paraquat in the blood through haemoperfusion or haemodialysis. The effectiveness of standard treatments is extremely limited.The immune system plays an important role in exacerbating paraquat-induced lung fibrosis. Immunosuppressive treatment using glucocorticoid and cyclophosphamide in combination is being developed and studied.
OBJECTIVES:
To assess the effects of glucocorticoid with cyclophosphamide on mortality in patients with paraquat-induced lung fibrosis.
SEARCH METHODS:
The most recent search was run on the 15th April 2014. We searched the Cochrane Injuries Group's Specialised Register, The Cochrane Library, Ovid MEDLINE(R), Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid OLDMEDLINE(R), Embase Classic+Embase (Ovid), ISI WOS (SCI-EXPANDED, SSCI, CPCI-S & CPSI-SSH), trials registries, Chinese databases (, , ) and reference lists.
SELECTION CRITERIA:
RCTs were included in this review. All patients were to receive standard care, plus the intervention or control. The intervention was glucocorticoid with cyclophosphamide in combination versus a control of a placebo, standard care alone or any other therapy in addition to standard care.
DATA COLLECTION AND ANALYSIS:
The mortality risk ratio (RR) and 95% confidence interval (CI) was calculated for each study on an intention-to-treat basis. Data for all-cause mortality at final follow-up were summarised in a meta-analysis using a fixed-effect model.
MAIN RESULTS:
This systematic review includes three trials with a combined total of 164 participants who had moderate to severe paraquat poisoning. Patients who received glucocorticoid with cyclophosphamide in addition to standard care had a lower risk of death at final follow-up than those receiving standard care only (RR 0.72; 95% CI 0.59 to 0.89).
AUTHORS' CONCLUSIONS:
Based on the findings of three small RCTs of moderate to severely poisoned patients, glucocorticoid with cyclophosphamide in addition to standard care may be a beneficial treatment for patients with paraquat-induced lung fibrosis. To enable further study of the effects of glucocorticoid with cyclophosphamide for patients with moderate to severe paraquat poisoning, hospitals may provide this treatment as part of an RCT with allocation concealment.
AuthorsLuying Ryan Li, Emma Sydenham, Bhuwan Chaudhary, Deirdre Beecher, Chao You
JournalThe Cochrane database of systematic reviews (Cochrane Database Syst Rev) Issue 8 Pg. CD008084 (Aug 07 2014) ISSN: 1469-493X [Electronic] England
PMID25099931 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Chemical References
  • Glucocorticoids
  • Herbicides
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Paraquat
Topics
  • Cause of Death
  • Cyclophosphamide (therapeutic use)
  • Drug Therapy, Combination (methods)
  • Glucocorticoids (therapeutic use)
  • Herbicides (poisoning)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Paraquat (poisoning)
  • Poisoning (mortality)
  • Pulmonary Fibrosis (chemically induced, drug therapy, immunology, mortality)
  • Randomized Controlled Trials as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: